Sandoz

Pharmaceuticals sector, China+1, CDMO companies, exports, drug development, commercial manufacturing, generics pharmaceutical drugs, funding

Sandoz launches biosimilar to treat chronic inflammatory diseases across Europe

Pyzchiva is approved for treatment of adults with plaque psoriasis, psoriatic arthritis, Crohn’s disease and pediatric plaque psoriasis for patients…

July 25, 2024 11:01 IST

European Commission grants approval to Sandoz denosumab biosimilars in Europe

European Commission grants approval to Sandoz’s denosumab biosimilars in Europe

According to the company’s statement, Wyost is approved for the treatment of cancer-related bone disease. Jubbonti is approved to treat…

May 22, 2024 11:30 IST

Sandoz reaches agreement with Amgen to resolve all patent litigation related to its denosumab biosimilars

Sandoz received FDA approval for the first and only denosumab biosimilars, Jubbonti and Wyost, on March 5, 2024.

May 1, 2024 13:01 IST

European Commission gives nod to Sandoz’s biosimilar to treat autoimmune disorders

In September 2023, Sandoz entered into a development and commercialization agreement for biosimilar ustekinumab with Samsung Bioepis.

April 23, 2024 15:26 IST

Sandoz opens new antibiotic production facility in Austria, to increase capacity for life-saving medicines

Sandoz has the only major remaining vertically integrated production network for penicillin in Europe.

March 24, 2024 14:18 IST

Sandoz gets FDA approval for first and only denosumab biosimilars

Wyost and Jubbonti have the same dosage form, route of administration, dosing regimen and presentation as the respective reference medicines.

March 6, 2024 11:16 IST

Jami Balaji Rao, Jami Balaji Rao career, Jami Balaji Rao education, Jami Balaji Rao net worth

Sandoz US subsidiaries resolve generic drug antitrust class action litigation

The full amount of the payment will be included in the company’s 2023 financial results, the company stated.

March 1, 2024 10:04 IST

Sandoz, Sandoz Biosimilars, multiple sclerosis, biosimilars in germany, Tyruko, healthcare news, pharma news,

Sandoz launches biosimilar for multiple sclerosis in Germany

In 2019, Sandoz entered into a global commercialization agreement for biosimilar natalizumab with Polpharma Biologics.

January 31, 2024 12:47 IST

Sandoz to acquire biosimilar to treat eye disorders from Coherus BioSciences

The agreement to acquire the CIMERLI business from Coherus allows us to build a more robust ophthalmic platform that would…

January 22, 2024 12:03 IST

Sandoz, Hyrimoz, Sandoz news, healthcare news, pharma news,

Sandoz launches Hyrimoz formulation for treating Crohn’s disease in Europe

It has a global portfolio with eight marketed biosimilars and a further 25 assets in various stages of development.

November 21, 2023 15:42 IST

Sandoz, Sandoz generics, generic drugs, biosimilars, healthcare news, pharma news,

Sandoz inaugurates new antibiotic production plant in Austria and new biosimilar development center in Germany

The EUR 25 million Holzkirchen investment will pave the way for the German site to become the leading Sandoz analytical…

November 14, 2023 09:00 IST

Sandoz, Sandoz eurobonds, healthcare news, pharma news, sandoz news,

Sandoz successfully issues EUR 2.0 billion inaugural Eurobonds

The transaction was led by BNP Paribas, J.P. Morgan and Mizuho as Active Bookrunners; Advestra and Linklaters acted as legal…

November 9, 2023 12:26 IST

Novartis, Novartis phase 3 trial, chronic hives, allergy, healthcare news, pharma news,

Sandoz starts share trading on SIX Swiss Exchange as independent company after 100 percent spin-off from Novartis

Generics and biosimilars account for an estimated 80 percent of medicines used worldwide by volume, at about 25 percent of…

October 4, 2023 12:16 IST

Novartis executes Sandoz Spin-off; To ‘fully’ focus on innovative medicines

With its new strategy unveiled in 2022, Novartis has now transformed into a focused innovative medicines business, concentrated on four…

October 4, 2023 11:09 IST

Sandoz, Biosimilar, multiple sclerosis, european markets, healthcare news, pharma news,

Sandoz gets European Commission approval for multiple sclerosis biosimilar in Europe

Sandoz has a leading global portfolio with eight marketed biosimilars and a further 25 assets in various stages of development.…

September 26, 2023 11:01 IST

Sandoz, Sandoz biosimilar, gastric cancer, healthcare news, pharma news,

Sandoz receives positive CHMP opinion for breast and gastric cancer biosimilar

In Europe, the impact of both breast and gastric cancers is significant. Every year, over 355,000 women are diagnosed with…

September 18, 2023 11:34 IST

Sandoz, Generic drugs, Novartis, immunology, healthcare news, pharma news,

Sandoz announces exclusive deal to commercialise biosimilar ustekinumab, reinforces immunology patient offering

Psoriasis is a chronic inflammatory disease of the skin and other parts of the body, which affects 60 million people…

September 11, 2023 10:57 IST

Drug Prices, Diabetes, Anxiety, NPPA, healthcare news, pharma news,

Sandoz strengthens pipeline expansion through partnership with Just-Evotec Biologics to develop, manufacture multiple biosimilars

Under the terms of the agreement, Sandoz has the optionality to use this technology, the company said in a statement.

May 10, 2023 16:04 IST

Related News

Aadhaar rule change 2025: New UIDAI update fees, PAN-Aadhaar link and KYC rules explained

Aadhaar rule change 2025: New UIDAI update fees, PAN-Aadhaar linking and KYC rules explained

Mohammad Mustafa, Razia Sultana, Akil Akhter, Aqil Akhter, Punjab dgp, Panchkula, Punjab news, Punjab murder

Ex-Punjab DGP, his former minister wife in trouble over son’s death; deceased’s 2 videos unravel murky details

UK immigration new rules, Skilled Worker visa changes, Graduate visa months, UK visa reforms, High Potential Individual route, UK student visa rules, UK Visa English requirement

UK announces major changes in immigration rules for overseas students and foreign workers

Aadhaar Card update October 2025: Here's how to change name, address, date of birth and phone number online in simple steps

Aadhaar Card new update October 2025: Here’s how to change name, address, date of birth and phone number online in simple steps

Green card holders, 2025 Naturalization Civics Test full list, 2025 civics test, U.S. citizenship, naturalization process, US immigration policy, new naturalization civics test 2025, USCIS 2025 citizenship test

US announces 2025 civics test for green card holders starting today

Expect loan, deposit growth at 18-20% in FY26: DCB Bank MD

Business21 min ago

DCB Bank is targeting a growth of 18-20% in loans and deposits this year, with a reported loan growth of 19.14% and deposit growth of 18.8%. The recent GST reforms and repo rate cut have boosted expectations and impacted consumer behavior. The bank’s focus is on secured, small-ticket lending to SMEs and becoming a full-fledged financial partner. They also aim to reduce slippages.

View all shorts